Oxford Biomedica Plc New (OXBDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | 12-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,161 | 65,629 | 102,746 | 129,012 | 162,059 |
| Receivables | 70,721 | 63,813 | 51,620 | 30,775 | 43,439 |
| Inventories | 17,703 | 14,687 | 20,912 | 16,011 | 16,956 |
| Other current assets | 0 | 0 | 0 | 1 | 39 |
| TOTAL | $149,585 | $144,129 | $175,278 | $175,799 | $222,493 |
| Non-Current Assets | |||||
| PPE Net | 62,806 | 200,524 | 231,830 | 220,369 | 223,882 |
| Intangibles | 27,606 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 5,566 | 36,957 | 43,539 | 43,936 | 128,735 |
| TOTAL | $95,978 | $237,481 | $275,369 | $264,305 | $352,617 |
| Total Assets | $245,563 | $250,661 | $309,178 | $313,888 | $502,174 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 304 | 703 | 0 | N/A |
| Accounts payable and accrued liabilities | 25,276 | 28,317 | 33,977 | 22,144 | 32,815 |
| Other current liabilities | 48,404 | 30,009 | 34,333 | 27,505 | 28,986 |
| TOTAL | $79,121 | $63,109 | $74,652 | $55,123 | $67,025 |
| Non-Current Liabilities | |||||
| Long Term Debt | 41,790 | 43,057 | 49,453 | 47,932 | 48,126 |
| Deferred Revenues | 195 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 14,645 | 8,088 | 10,628 | 26,809 | 42,351 |
| TOTAL | $129,288 | $122,100 | $144,639 | $161,947 | $187,038 |
| Total Liabilities | $208,409 | $185,208 | $219,291 | $217,071 | $254,062 |
| Shareholders' Equity | |||||
| Common Shares | 60,245 | 57,331 | 66,455 | 60,208 | 60,426 |
| Retained earnings | -477,791 | -432,299 | -492,300 | -438,995 | -306,048 |
| Other shareholders' equity | 6,453 | 13,147 | 17,416 | 2,509 | 17,626 |
| TOTAL | $37,154 | $65,453 | $89,887 | $96,818 | $248,111 |
| Total Liabilities And Equity | $245,563 | $250,661 | $309,178 | $313,889 | $502,173 |